COCRYSTAL PHARMA, INC. Grants Receivable
COCRYSTAL PHARMA, INC. (COCP) had Grants Receivable of $70.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Notes › Nontrade Receivables
us-gaap:GrantsReceivable · last filed 2026-05-15
- 2026-03-31: Grants Receivable $70.00K.
- 2015-12-31: Grants Receivable $29.48K.
- 2014-12-31: Grants Receivable $32.82K; Grants Receivable as first filed $32.82M.
- 2013-12-31: Grants Receivable $1.65M.
| Period end | Grants Receivable | Grants Receivable as first filed |
|---|---|---|
| 2026-03-31 | $70.00K 10-Q · filed 2026-05-15 | |
| 2015-12-31 | $29.48K 10-K · filed 2016-03-15 | |
| 2014-12-31 | $32.82K 10-K · filed 2016-03-15 | $32.82M 10-K · filed 2015-03-31 |
| 2013-12-31 | $1.65M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |